The relationship between Mycobacterium avium complex (MAC) bacteremia and proinflammatory cytokine and human immunodeficiency virus type 1 (HIV-1) RNA levels in AIDS was investigated. During a prospective study, blood samples were drawn monthly for mycobacterial cultures. Sera were available at baseline and onset of MAC bacteremia from 20 cases and at corresponding times from 19 controls. Mean interleukin-6 (IL-6) levels were 154% greater at the time of MAC bacteremia in cases than in controls. The IL-6 levels correlated with body temperature, serum tumor necrosis factor (TNF-a) levels, and alkaline phosphatase levels (P £ .004 for each). Although TNF-a levels tended to rise more in MAC patients than in controls, the difference was not significant. However, among both cases and controls, serum TNF-a levels rose significantly from baseline to the time of last sample, irrespective of MAC infection (P Å .015). Bacteremia was not associated with increased serum HIV-1 RNA levels. Thus, early MAC bacteremia is associated with increases in serum IL-6 levels, while TNF-a levels rise over time during advanced AIDS.
Disseminated Mycobacterium avium complex (MAC) dis-
HIV-infected patients, active viral replication drives progressive CD4 cell depletion [4] . Current treatment strategies focus ease is common during advanced AIDS. Cellular expression of tumor necrosis factor-a (TNF-a) is induced by mycobacterial on minimizing HIV replication. The present study investigated whether early MAC bacteremia was associated with changes proteins in vitro [1] and during tuberculosis in human immunodeficiency virus (HIV) -infected persons [2] . In addition, imin serum IL-6, TNF-a, and HIV RNA levels in patients with AIDS. mune activating events such as febrile illnesses and immunizations cause transient increases in plasma HIV RNA. Cytokines that promote HIV expression in vitro, such as TNF-a and interleukin-6 (IL-6), may enhance HIV replication [3] . Among
Materials and Methods
Patients. Patients previously enrolled in a prospective clinical trial of clarithromycin prophylaxis in AIDS were studied [5] . Pa-matched for baseline CD4
/ cell count and time from baseline to Cases and controls had similar IL-6 and TNF-a levels at last serum sample.
baseline (table 1) between individual final and baseline IL-6 levels (to control for at least 1 week before the pertinent serum sample. Antiretrovifor interpatient variability), the change in IL-6 levels remained rals started after baseline but stopped at least 1 week before the significant (P Å .027).
pertinent sampling were not included in the analysis.
In contrast, although TNF-a levels tended to rise more Sample processing. Whole blood was collected, and serum among cases, the increase specifically associated with MAC was separated by centrifugation and stored at 070ЊC. Sera from bacteremia was not significant (table 1) . Levels of TNF-a were some time points were not available, and plasma samples were unavailable.
higher among both groups at final sample time (42.5 { 5.2 pg/ Cytokine assays. Sera were analyzed for TNF-a (Medgenix, mL) compared with baseline (28.4 { 2.4 pg/mL), regardless
Stillwater, MN) and IL-6 (R&D Systems, Minneapolis) in a of bacteremia (P Å .015). There was no correlation between blinded manner. The lower limit of IL-6 detection was 0.15 pg/ TNF-a levels and duration of storage (not shown).
mL. Lower values were censored to 0.15 pg/mL. The lower limit
The HIV RNA levels varied widely among the 39 subjects of TNF-a detection was 16 pg/mL. All results exceeded this level.
at all times, from õ500 copies/mL to 4,266,000 copies/mL. , and interval and ratio variables were assessed by Student's t test or Pearson's correlation coefficient. For multiple linear ability, the change over time in individual patients was calcuregression, entry and exit probabilities of .05 and .10 were used, lated based on the first and last sample. This difference was respectively. All P values were based on two-tailed tests. Subjects not significant.
with missing data were excluded from individual analyses.
We further examined the relationship between clinical characteristics and MAC bacteremia. Other than a trend toward higher mean body temperatures (99.2 { 0.4ЊF vs. 98.3 { 0.2ЊF, P Å .059) and lower hemoglobin levels (11.1 { 0.6 vs. 12.4 Results { 0.4 g/dL, P Å .069) in cases versus controls, respectively, Between November 1992 and July 1993, 682 patients with MAC bacteremia was not associated with changes in white blood cultures negative for mycobacteria at baseline particiblood, platelet, CD4, or CD8 cell counts or percentages, pated in a study of clarithromycin prophylaxis for disseminated serum alkaline phosphatase, triglycerides, or body weight MAC infection [5] . Of 334 randomized to placebo, 53 devel-(P ú .05). oped disseminated MAC infection, as defined by a positive blood culture. Twenty of these 53 patients, for whom adequate serum samples were available, were included in these analyses, In addition to baseline and time of MAC bacteremia, samprevious report, we identified patients from a prospective, randomized study which lasted for over a year [5] . Of interest, in ples from intermediate time points were available from some patients, yielding a total of 53 sera from cases and 54 from this prospective study, serum TNF-a levels rose in all patients irrespective of MAC disease, suggesting that TNF-a expression controls. Analysis of these 107 samples (including baseline and final samples) revealed that serum IL-6 correlated with alkaline increases over time in HIV disease as has been suggested by some [11] but not all [12] earlier cross-sectional studies. phosphatase (r Å .41, P õ .001) and body temperature (r Å .38, P õ .001). For TNF-a, weaker correlations were
The cytokines TNF-a and IL-6 participate in the host immune response to various intracellular pathogens, including observed with triglycerides (r Å .25, P Å .011) and hemoglobin (r Å 0.23, P Å .022). There was a strong correlation between mycobacteria. Increased production of TNF-a has been demonstrated during tuberculosis [1, 8] , and serum TNF-a levels IL-6 levels and TNF-a levels (r Å .38, P õ .001). Neither cytokine correlated with log HIV RNA.
fall when HIV-infected adults with active tuberculosis receive effective therapy [13] . While the mechanisms involved are not We repeated the above analyses after controlling for antiretroviral use. At baseline, 19 (95%) cases and 17 (89.5%) conwell understood, exposure of peripheral blood mononuclear cells from healthy, tuberculin-positive volunteers to live Mycotrols were receiving at least one antiretroviral agent, for a mean of 1.10 ({0.10) and 1.16 ({0.14) agents per case and control bacterium tuberculosis induces transcription of TNF-a and IL-6 mRNA. Similarly, mononuclear cells from patients with acpatient, respectively. At the time of final sample, 5 patients in each group had started at least one new agent. In addition, tive pulmonary tuberculosis demonstrate elevated cytokine mRNA levels and increased production of TNF-a in response some drugs received at baseline were discontinued, so that at study end controls and cases were receiving a mean of 1.0 { to exogenous stimuli [8] . During mycobacterial infection, TNFa may be involved in immune pathways that result in fever 0.2 and 0.8 { 0.1 agents, respectively.
When the 10 patients who started new agents were compared and tissue necrosis, inhibit mycobacterial growth, and promote granuloma formation. Furthermore, TNF-a facilitates killing with the other 29 patients, there was no difference in IL-6, TNF-a, or log HIV RNA levels from baseline to final sample of intracellular MAC, while both TNF-a and IL-6 production may correlate with increased survival of MAC-infected macro-(P ú .05 for each). Although the number of patients was small, among the 20 MAC case patients, there were no significant phages [14] . The physiologic effects of TNF-a and IL-6 occur largely in differences in changes in IL-6, TNF-a, or log HIV RNA levels among the 5 patients who had new antiretrovirals added comthe local tissue microenvironment at sites of infection. In the present study, activation of cytokine or HIV-1 expression may pared with the 15 who did not.
Infectious or neoplastic complications other than MAC bachave been greater in the tissues during MAC bacteremia but was not reflected by circulating levels. Our findings of changes teremia could influence cytokine or HIV-1 RNA levels. However, such events were equally distributed between groups. At in IL-6 but not TNF-a or HIV-1 RNA levels may also reflect stage of MAC disease. In the present study, MAC bacteremia least one major infectious or neoplastic disease was diagnosed after collection of baseline but before last serum samples in 9 was probably diagnosed before extensive lymphoreticular organ involvement. This was predicted by the study design, which case and 9 control patients, and included cytomegalovirus retinitis (7), Pneumocystis carinii pneumonia (4), Kaposi's sarinvolved monthly blood cultures, regardless of symptoms, and is supported by the minimal clinical abnormalities specifically coma (3), nonretinal cytomegalovirus disease (2), bacterial pneumonia (2), and lymphoma, pancreatitis, and intravenous associated with bacteremia. This differs from the usual stage of diagnosis, by which time patients typically have high-grade catheter infection (1 each). All non-MAC infections except 2 were diagnosed at least 1 month prior to MAC bacteremia (1 fever and anemia. A report describing increased TNF-a levels during MAC involved such clinically overt disease [10] . in a case, 1 in a control). When these 2 subjects were excluded from analysis, final IL-6 levels remained higher in cases (14. 4 In contrast to the present study, Havlir et al. [15] observed increased circulating HIV-1 RNA levels during early MAC { 3.7 pg/mL) than controls (5.6 { 1.0 pg/mL, P Å .031), and final temperatures remained higher in cases (99.3 { 0.4ЊF) than bacteremia. Elevated IL-6 levels may precede HIV-1 RNA increases in bacteremic patients. It is possible that, in the prescontrols (98.3 { 0.2ЊF, P Å .04) ent study, increased HIV-1 RNA levels would have been observed at later times.
Discussion
Improved culture methods and newer macrolide antibiotics have influenced the approach to MAC infections in patients This study demonstrates that early MAC bacteremia is associated with increased serum IL-6 but not TNF-a or HIV RNA with AIDS [5] . We have shown that onset of MAC bacteremia may be associated with minimal clinical or laboratory evidence levels. These findings were unexpected given the strong association between tuberculosis and increased expression of both of disease, increased IL-6 levels, and little evidence of TNFa or HIV RNA changes. The opportunity for early preemptive proinflammatory cytokines and HIV [2, 8, 9] . In addition, a previous study demonstrated elevated TNF-a levels among therapy at the time of minimal pathogenic effect should abort subsequent clinical disease and complications. However, in the patients with disseminated MAC infection [10] . Unlike the / 9d46$$ju46 05-11-98 10:41:02 jinfa UC: J Infect
